- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- The ReproPsych Group
- CAS Newsletter
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
2013 FACE meeting
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting .
- Read more in our News Archive
Current Studies at Motherisk
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Am J Obstet Gynecol 172(4 Pt 1): 1307-11, 1995.
Magee LA, Downar E, Sermer M, Koren G: Pregnancy outcome following gestational exposure to amiodarone in Canada.
Am J Obstet Gynecol 174: 823-828, 1996.
Magee LA, Schick B, Sage S, Conover B, Cook L, McElhaton, Raman-Williams L, Schmidt M, Koren G: The safety of calcium channel blockers in human pregnancy.
Eur J Obstet Gynecol Reprod Biol. 2000 Jan;88(1):15-26.
Magee LA, Elran E, Bull SB, Logan A, Koren G: Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials.
Neurotoxicol Teratol. 1999 May-Jun;21(3):261-5.
Magee LA, Nulman I, Rovet JF, Koren G: Neurodevelopment after in utero amiodarone exposure
Am J Hematol. 1999 Feb;60(2):148-50. Review.
Diav-Citrin O, Hunnisett L, Sher GD, Koren G: Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature.